Diagnosi molecolare nella neurofibromatosi tipo 1

Translated title of the contribution: Molecular diagnosis in neurofibromatosis type 1

E. Bonioli, S. Costabel, A. Di Stefano, C. La Rosa, A. Citana, S. Massa, D. Coviello, F. Ajmar, P. Origone

Research output: Contribution to journalArticle

Abstract

Type 1 Neurofibromatosis is a frequent autosomal dominant disorder occurring approximately 1 in 3000 live births. The mutation rate is very high and approximately 50% of the patients are sporadic cases. NF1 is solely diagnosed on the basis of its clinical features which include cafè-au-lait spots, axillary and inguinal freckling, peripheral neurofibromas and Lisch nodules. A wide range of other complications can occur in NF1 patients, including plexiform neurofibromas, optic and chiasma gliomas, learning disabilities, scoliosis, pseudarthrosis and malignancy. Molecular analysis of NF1 gene is quite complex due to its large size (350 Kb) and to the heterogeneity of the mutations described. A protein truncation assay (PTT) has recently been developed, which allows the detection of approximately 50% of germline mutations in the gene. In our study we detected 18 truncated fragments indicating abnormal polypeptide in heterozygous condition, and 14 of these have been fully characterised by direct sequencing. We have diagnosed six mutations (C2041T, A2428T, C3816T, C4084T, C5380T, C5839T) three small deletions (2674delA, 7190-91delCT, 7331delA), four small insertions (1021-22insTT, 2027insC, 4106insTA, 7149insC) and one A-> C mutation in splice accepting site of intron 13. The extreme variability of the phenotypic expression of NF1 gene makes reproductive decisions in NF1 families very difficult, as molecular diagnosis cannot predict clinical expression of the disease. We have performed four prenatal diagnosis. In three cases the linkage analysis was carried out using informative markers. Direct approach using Protein Truncation Test and sequencing was performed in one case, in which a R1947X mutation was identified. Our experience confirms an evenly distribution of NF1 mutations over the entire coding region.

Original languageItalian
Pages (from-to)35-39
Number of pages5
JournalGaslini
Volume33
Issue number1
Publication statusPublished - 2001

Fingerprint

Neurofibromatosis 1
Mutation
Plexiform Neurofibroma
Optic Nerve Glioma
Optic Chiasm
Neurofibroma
Pseudarthrosis
Germ-Line Mutation
Groin
Learning Disorders
Live Birth
Scoliosis
Mutation Rate
Prenatal Diagnosis
Introns
Genes
Proteins
Gene Expression
Peptides
Neoplasms

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Bonioli, E., Costabel, S., Di Stefano, A., La Rosa, C., Citana, A., Massa, S., ... Origone, P. (2001). Diagnosi molecolare nella neurofibromatosi tipo 1. Gaslini, 33(1), 35-39.

Diagnosi molecolare nella neurofibromatosi tipo 1. / Bonioli, E.; Costabel, S.; Di Stefano, A.; La Rosa, C.; Citana, A.; Massa, S.; Coviello, D.; Ajmar, F.; Origone, P.

In: Gaslini, Vol. 33, No. 1, 2001, p. 35-39.

Research output: Contribution to journalArticle

Bonioli, E, Costabel, S, Di Stefano, A, La Rosa, C, Citana, A, Massa, S, Coviello, D, Ajmar, F & Origone, P 2001, 'Diagnosi molecolare nella neurofibromatosi tipo 1', Gaslini, vol. 33, no. 1, pp. 35-39.
Bonioli E, Costabel S, Di Stefano A, La Rosa C, Citana A, Massa S et al. Diagnosi molecolare nella neurofibromatosi tipo 1. Gaslini. 2001;33(1):35-39.
Bonioli, E. ; Costabel, S. ; Di Stefano, A. ; La Rosa, C. ; Citana, A. ; Massa, S. ; Coviello, D. ; Ajmar, F. ; Origone, P. / Diagnosi molecolare nella neurofibromatosi tipo 1. In: Gaslini. 2001 ; Vol. 33, No. 1. pp. 35-39.
@article{172a9cea4f214e4891e4fa094554e00b,
title = "Diagnosi molecolare nella neurofibromatosi tipo 1",
abstract = "Type 1 Neurofibromatosis is a frequent autosomal dominant disorder occurring approximately 1 in 3000 live births. The mutation rate is very high and approximately 50{\%} of the patients are sporadic cases. NF1 is solely diagnosed on the basis of its clinical features which include caf{\`e}-au-lait spots, axillary and inguinal freckling, peripheral neurofibromas and Lisch nodules. A wide range of other complications can occur in NF1 patients, including plexiform neurofibromas, optic and chiasma gliomas, learning disabilities, scoliosis, pseudarthrosis and malignancy. Molecular analysis of NF1 gene is quite complex due to its large size (350 Kb) and to the heterogeneity of the mutations described. A protein truncation assay (PTT) has recently been developed, which allows the detection of approximately 50{\%} of germline mutations in the gene. In our study we detected 18 truncated fragments indicating abnormal polypeptide in heterozygous condition, and 14 of these have been fully characterised by direct sequencing. We have diagnosed six mutations (C2041T, A2428T, C3816T, C4084T, C5380T, C5839T) three small deletions (2674delA, 7190-91delCT, 7331delA), four small insertions (1021-22insTT, 2027insC, 4106insTA, 7149insC) and one A-> C mutation in splice accepting site of intron 13. The extreme variability of the phenotypic expression of NF1 gene makes reproductive decisions in NF1 families very difficult, as molecular diagnosis cannot predict clinical expression of the disease. We have performed four prenatal diagnosis. In three cases the linkage analysis was carried out using informative markers. Direct approach using Protein Truncation Test and sequencing was performed in one case, in which a R1947X mutation was identified. Our experience confirms an evenly distribution of NF1 mutations over the entire coding region.",
keywords = "Molecular analysis, Neurofibromatosis type 1, Prenatal diagnosis, Protein truncation test",
author = "E. Bonioli and S. Costabel and {Di Stefano}, A. and {La Rosa}, C. and A. Citana and S. Massa and D. Coviello and F. Ajmar and P. Origone",
year = "2001",
language = "Italian",
volume = "33",
pages = "35--39",
journal = "Gaslini",
issn = "0390-5845",
publisher = "Masson SpA",
number = "1",

}

TY - JOUR

T1 - Diagnosi molecolare nella neurofibromatosi tipo 1

AU - Bonioli, E.

AU - Costabel, S.

AU - Di Stefano, A.

AU - La Rosa, C.

AU - Citana, A.

AU - Massa, S.

AU - Coviello, D.

AU - Ajmar, F.

AU - Origone, P.

PY - 2001

Y1 - 2001

N2 - Type 1 Neurofibromatosis is a frequent autosomal dominant disorder occurring approximately 1 in 3000 live births. The mutation rate is very high and approximately 50% of the patients are sporadic cases. NF1 is solely diagnosed on the basis of its clinical features which include cafè-au-lait spots, axillary and inguinal freckling, peripheral neurofibromas and Lisch nodules. A wide range of other complications can occur in NF1 patients, including plexiform neurofibromas, optic and chiasma gliomas, learning disabilities, scoliosis, pseudarthrosis and malignancy. Molecular analysis of NF1 gene is quite complex due to its large size (350 Kb) and to the heterogeneity of the mutations described. A protein truncation assay (PTT) has recently been developed, which allows the detection of approximately 50% of germline mutations in the gene. In our study we detected 18 truncated fragments indicating abnormal polypeptide in heterozygous condition, and 14 of these have been fully characterised by direct sequencing. We have diagnosed six mutations (C2041T, A2428T, C3816T, C4084T, C5380T, C5839T) three small deletions (2674delA, 7190-91delCT, 7331delA), four small insertions (1021-22insTT, 2027insC, 4106insTA, 7149insC) and one A-> C mutation in splice accepting site of intron 13. The extreme variability of the phenotypic expression of NF1 gene makes reproductive decisions in NF1 families very difficult, as molecular diagnosis cannot predict clinical expression of the disease. We have performed four prenatal diagnosis. In three cases the linkage analysis was carried out using informative markers. Direct approach using Protein Truncation Test and sequencing was performed in one case, in which a R1947X mutation was identified. Our experience confirms an evenly distribution of NF1 mutations over the entire coding region.

AB - Type 1 Neurofibromatosis is a frequent autosomal dominant disorder occurring approximately 1 in 3000 live births. The mutation rate is very high and approximately 50% of the patients are sporadic cases. NF1 is solely diagnosed on the basis of its clinical features which include cafè-au-lait spots, axillary and inguinal freckling, peripheral neurofibromas and Lisch nodules. A wide range of other complications can occur in NF1 patients, including plexiform neurofibromas, optic and chiasma gliomas, learning disabilities, scoliosis, pseudarthrosis and malignancy. Molecular analysis of NF1 gene is quite complex due to its large size (350 Kb) and to the heterogeneity of the mutations described. A protein truncation assay (PTT) has recently been developed, which allows the detection of approximately 50% of germline mutations in the gene. In our study we detected 18 truncated fragments indicating abnormal polypeptide in heterozygous condition, and 14 of these have been fully characterised by direct sequencing. We have diagnosed six mutations (C2041T, A2428T, C3816T, C4084T, C5380T, C5839T) three small deletions (2674delA, 7190-91delCT, 7331delA), four small insertions (1021-22insTT, 2027insC, 4106insTA, 7149insC) and one A-> C mutation in splice accepting site of intron 13. The extreme variability of the phenotypic expression of NF1 gene makes reproductive decisions in NF1 families very difficult, as molecular diagnosis cannot predict clinical expression of the disease. We have performed four prenatal diagnosis. In three cases the linkage analysis was carried out using informative markers. Direct approach using Protein Truncation Test and sequencing was performed in one case, in which a R1947X mutation was identified. Our experience confirms an evenly distribution of NF1 mutations over the entire coding region.

KW - Molecular analysis

KW - Neurofibromatosis type 1

KW - Prenatal diagnosis

KW - Protein truncation test

UR - http://www.scopus.com/inward/record.url?scp=0034976356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034976356&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0034976356

VL - 33

SP - 35

EP - 39

JO - Gaslini

JF - Gaslini

SN - 0390-5845

IS - 1

ER -